Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2024-07-27 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (NSE and BSE) regarding a regulatory notice received from the Goods and Service Tax (GST) Authority. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material events. The content details a GST demand notice (Form GST ASMT-10) for the fiscal period 2020-2021, with no immediate financial impact expected. The document is a regulatory announcement about a legal/tax matter, not a financial report, earnings release, or management discussion. It is a compliance disclosure under SEBI regulations, fitting the category of Regulatory Filings (RNS). The document length is short (3363 characters), and it is not an announcement of a report publication but a direct disclosure. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2024-07-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call held on July 24, 2024, discussing the unaudited standalone and consolidated financial results for the quarter ended June 30, 2024. It includes detailed management commentary on financial performance, business highlights, product launches, market outlook, and Q&A with analysts. The presence of a moderator, management speakers, and Q&A session confirms it is a full transcript of the earnings call. The document length is 15,000 characters, indicating it is a full transcript rather than a brief announcement. Therefore, the document fits the category of a Call Transcript (CT).
2024-07-26 English
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides details about an order received from the Goods and Service Tax (GST) Authority regarding an appeal filed by the company. The document includes a summary of the order, the financial impact, and the company's intended response. It is addressed to stock exchanges and is a regulatory announcement about a legal/tax matter. The document length is 3143 characters, which is relatively short and does not contain detailed financial statements or comprehensive report data. It is not an annual or interim report, earnings release, or audit report. It is a regulatory filing disclosing a material event as required by stock exchange regulations. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-07-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a letter addressed to stock exchanges regarding the availability of the audio recording of an earnings conference call for the quarter ended June 30, 2024. It references the SEBI regulations and provides a link to the recording on the company's website. The document does not contain the transcript itself or detailed financial data, but rather announces the availability of the call recording. This fits the definition of a Call Transcript (CT) related announcement, but since it only announces the recording and does not provide the transcript text, it is best classified as a Regulatory Filing (RNS) as a general announcement. However, given the specific nature of the content focusing on the earnings call, the closest specific category is Call Transcript (CT). The document length is short and it does not contain the transcript itself, but the announcement is about the earnings call recording. Therefore, the best classification is Call Transcript (CT) with high confidence.
2024-07-24 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of unaudited standalone and consolidated financial results for the quarter ended 30th June 2024. It references Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements), 2015, and mentions that newspaper advertisements containing extracts of the financial results have been published. The document itself is short (1579 characters) and serves as a notification of the publication of financial results rather than containing the full financial report or detailed financial data. Therefore, it is an announcement related to the earnings release but not the earnings release itself. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the publication of financial results, not the full earnings release report or transcript.
2024-07-24 English
Financial Result Updates
Regulatory Filings
2024-07-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.